ஐ.எஸ்.எஸ்.என்: 2155-9880
Yuichi Ozaki*, Atsushi Tanaka
Percutaneous Coronary Intervention (PCI) has been increasingly utilized for the treatment of coronary artery disease; however, no-reflow phenomenon is one of the crucial complications during PCI. Patients with no-reflow phenomenon are associated with poor clinical outcomes when compared with patients with adequate reflow after reperfusion therapy, and no-reflow phenomenon is an independent prognostic factor. Thus, it is clinically important to predict and if possible, prevent no-reflow phenomenon during PCI. Here, we demonstrate the possibilities and evidences of the tools which are used in the clinical practice for predicting no-reflow phenomenon.